Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rotrosen

Showing results (91-100 of 130) with videos related to

Pageof 13
Sort By:
Archives of General Psychiatry|December 1, 1992
Negative symptoms and hypofrontality in chronic schizophreniaA Wolkin, M Sanfilipo, A P Wolf, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Clinical stages of dementia and the dexamethasone suppression testM Serby, D Zucker, M Kaufman, et al.
Journal of Neural Transmission|January 1, 1979
Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidolB Angrist, M Ain, J Rotrosen, et al.
The American Journal of Psychiatry|August 1, 1978
Suppression of prolactin by dopamine agonists in schizophrenics and controlsJ Rotrosen, B Angrist, C Clark, et al.
Psychopharmacology|January 1, 1987
Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophreniaE Peselow, B Angrist, A Sudilovsky, et al.
The American Journal of Psychiatry|September 1, 1993
Vitamin E treatment of tardive dyskinesiaL A Adler, E Peselow, J Rotrosen, et al.
Biological Psychiatry|October 15, 1993
Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenicsE Duncan, A Wolkin, B Angrist, et al.
Biological Psychiatry|June 17, 1998
Long-term treatment effects of vitamin E for tardive dyskinesiaL A Adler, R Edson, P Lavori, et al.
Journal of Clinical Psychopharmacology|October 1, 1986
The dexamethasone suppression test and response to placeboE D Peselow, A Lautin, A Wolkin, et al.
Psychopharmacology|July 1, 1997
Reliability of an instrumental assessment of tardive dyskinesia: results from VA Cooperative Study #394M P Caligiuri, J B Lohr, J Rotrosen, et al.
Pageof 13

Showing results (91-100 of 130) with videos related to

Sort By:
Pageof 13
Archives of General Psychiatry|December 1, 1992
Negative symptoms and hypofrontality in chronic schizophreniaA Wolkin, M Sanfilipo, A P Wolf, et al.
Progress in Neuro-Psychopharmacology & Biological Psychiatry|January 1, 1988
Clinical stages of dementia and the dexamethasone suppression testM Serby, D Zucker, M Kaufman, et al.
Journal of Neural Transmission|January 1, 1979
Behavioral and neuroendocrine effects of low dose ET-495: antagonism by haloperidolB Angrist, M Ain, J Rotrosen, et al.
The American Journal of Psychiatry|August 1, 1978
Suppression of prolactin by dopamine agonists in schizophrenics and controlsJ Rotrosen, B Angrist, C Clark, et al.
Psychopharmacology|January 1, 1987
Double blind controlled trials of cholecystokinin octapeptide in neuroleptic-refractory schizophreniaE Peselow, B Angrist, A Sudilovsky, et al.
The American Journal of Psychiatry|September 1, 1993
Vitamin E treatment of tardive dyskinesiaL A Adler, E Peselow, J Rotrosen, et al.
Biological Psychiatry|October 15, 1993
Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenicsE Duncan, A Wolkin, B Angrist, et al.
Biological Psychiatry|June 17, 1998
Long-term treatment effects of vitamin E for tardive dyskinesiaL A Adler, R Edson, P Lavori, et al.
Journal of Clinical Psychopharmacology|October 1, 1986
The dexamethasone suppression test and response to placeboE D Peselow, A Lautin, A Wolkin, et al.
Psychopharmacology|July 1, 1997
Reliability of an instrumental assessment of tardive dyskinesia: results from VA Cooperative Study #394M P Caligiuri, J B Lohr, J Rotrosen, et al.
Pageof 13